SK4699A3 - Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation - Google Patents

Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation Download PDF

Info

Publication number
SK4699A3
SK4699A3 SK46-99A SK4699A SK4699A3 SK 4699 A3 SK4699 A3 SK 4699A3 SK 4699 A SK4699 A SK 4699A SK 4699 A3 SK4699 A3 SK 4699A3
Authority
SK
Slovakia
Prior art keywords
phenyl
acid
compound
formula
prepared
Prior art date
Application number
SK46-99A
Other languages
English (en)
Slovak (sk)
Inventor
Eva Akerblom
Martin Haraldsson
Rolf Johansson
Katarina Beierlein
Birger Sjoberg
Erik Ringberg
Birgitta Weinz
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9602890A external-priority patent/SE9602890D0/xx
Priority claimed from SE9602888A external-priority patent/SE9602888D0/xx
Priority claimed from SE9602889A external-priority patent/SE9602889D0/xx
Priority claimed from SE9602887A external-priority patent/SE9602887D0/xx
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of SK4699A3 publication Critical patent/SK4699A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/12—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
SK46-99A 1996-07-29 1997-07-23 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation SK4699A3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9602890A SE9602890D0 (sv) 1996-07-29 1996-07-29 Carboxylic esters, their use and preparation
SE9602888A SE9602888D0 (sv) 1996-07-29 1996-07-29 Carboxylic esters, their use and preparation
SE9602889A SE9602889D0 (sv) 1996-07-29 1996-07-29 Carboxylic esters, their use and preparation
SE9602887A SE9602887D0 (sv) 1996-07-29 1996-07-29 Carboxylic esters, their use and preparation
PCT/SE1997/001310 WO1998004517A1 (en) 1996-07-29 1997-07-23 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation

Publications (1)

Publication Number Publication Date
SK4699A3 true SK4699A3 (en) 2000-04-10

Family

ID=27484794

Family Applications (1)

Application Number Title Priority Date Filing Date
SK46-99A SK4699A3 (en) 1996-07-29 1997-07-23 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation

Country Status (17)

Country Link
US (1) US6124354A (zh)
EP (1) EP0923536A1 (zh)
JP (1) JP2000515881A (zh)
KR (1) KR20000029703A (zh)
CN (1) CN1226886A (zh)
AU (1) AU724563B2 (zh)
BG (1) BG103207A (zh)
BR (1) BR9710614A (zh)
CA (1) CA2261692A1 (zh)
EE (1) EE9900034A (zh)
IL (1) IL128096A0 (zh)
NO (1) NO990335L (zh)
NZ (1) NZ333798A (zh)
PL (1) PL331384A1 (zh)
SK (1) SK4699A3 (zh)
TR (1) TR199900185T2 (zh)
WO (1) WO1998004517A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020547A1 (es) 2000-10-24 2002-06-12 Upjohn Co Uso de la tolterodina en tratamientos del asma
EP1441706A2 (en) * 2001-11-05 2004-08-04 Pharmacia &amp; Upjohn Company Antimuscarinic aerosol
US8481518B2 (en) * 2003-01-16 2013-07-09 University Of Rochester Quaternary antimuscarinic compounds for the treatment of bladder diseases
WO2008059239A1 (en) * 2006-11-14 2008-05-22 Astrazeneca Ab Novel compounds 514
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
BRPI0912657A2 (pt) * 2008-05-13 2016-01-26 Astrazeneca Ab produto farmacêutico compreendendo um antagonista de receptor muscarínico e um agonista beta2-adrenorreceptor
BRPI0822693A2 (pt) 2008-05-13 2015-07-07 Astrazeneca Ab Derivados de quinuclidina como antagonistas do receptor muscarínico m3
WO2012145234A2 (en) * 2011-04-21 2012-10-26 Emory University Cyclopropyl derivatives and methods of use
MA37975B2 (fr) * 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
TW201517906A (zh) 2013-07-25 2015-05-16 Almirall Sa 含有ｍａｂａ化合物和皮質類固醇之組合
TW201617343A (zh) * 2014-09-26 2016-05-16 阿爾米雷爾有限公司 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物
CN106083615B (zh) * 2016-06-08 2019-03-08 山东省药学科学院 一种盐酸环喷托酯的制备方法
JP7134173B2 (ja) 2017-06-21 2022-09-09 第一三共株式会社 Ｅｐ３００／ｃｒｅｂｂｐ阻害剤
BR112023000798A2 (pt) 2020-07-24 2023-02-07 Genzyme Corp Composições farmacêuticas compreendendo venglustat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2168881A1 (en) * 1972-01-25 1973-09-07 Synthelabo Tropanol 1-phenylcycloalkane carboxylic ester salts - spasmolytics and cholinergics
US4418202A (en) * 1981-12-21 1983-11-29 Emery Industries, Inc. 2-Vinyl- and 2-ethylcyclopropane monocarboxylates
DD289411A7 (de) * 1984-06-29 1991-05-02 Arzneimittelwerk Dresden Gmbh,De Verfahren zur herstellung eines antidos fuer phosphororganische verbindungen
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
US5086054A (en) * 1990-07-31 1992-02-04 Sri International Novel arylcycloalkanepolyalkylamines
US5064850A (en) * 1991-04-08 1991-11-12 Marion Merrell Dow Inc. Dihydro-3,3-diphenyl-5-(1H-pyrazol-1-ylmethyl-2(3H)-furanone and dihydro-5-((substituted-1H-pyrazol-1-yl)methyl)-3,3-diphenyl-2(3H)-furanone derivatives
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands

Also Published As

Publication number Publication date
WO1998004517A1 (en) 1998-02-05
CA2261692A1 (en) 1998-02-05
EP0923536A1 (en) 1999-06-23
JP2000515881A (ja) 2000-11-28
BR9710614A (pt) 2000-01-11
TR199900185T2 (xx) 1999-04-21
US6124354A (en) 2000-09-26
EE9900034A (et) 1999-08-16
AU724563B2 (en) 2000-09-28
NO990335D0 (no) 1999-01-25
PL331384A1 (en) 1999-07-05
KR20000029703A (ko) 2000-05-25
AU3790597A (en) 1998-02-20
CN1226886A (zh) 1999-08-25
NZ333798A (en) 2000-08-25
BG103207A (en) 1999-10-29
IL128096A0 (en) 1999-11-30
NO990335L (no) 1999-03-29

Similar Documents

Publication Publication Date Title
CA2132541C (en) Quinuclidine derivatives as substance p antagonists
EP0591333B1 (en) Azanorbornane derivatives
EP0708771B1 (en) Benzyloxyquinuclidines as substance p antagonists
SK4699A3 (en) Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
US6890936B2 (en) Muscarinic antagonists
JPH0578354A (ja) アザ二環式化合物、これを含有する医薬組成物及び治療のための使用方法
SK15612002A3 (sk) Azabicyklické karbamáty, spôsob ich prípravy a farmaceutické prostriedky, ktoré ich obsahujú ako účinné látky
SK279168B6 (sk) Bicyklické 1-azacykloalkány, farmaceutické prostri
EP0783498A1 (en) Substituted aryl piperazines as neurokinin antagonists
CZ287272B6 (en) Quaternary basic amide, process of its preparation and pharmaceutical composition in which the amide is comprised
US4879300A (en) Novel piperidine derivatives
TW201406728A (zh) 具有ep1受體活性之經取代的三環化合物(二)
TWI441826B (zh) 經取代之四氫哌喃螺吡咯啶酮及六氫吡啶酮，彼等之製備與用途
US20080262075A1 (en) Pyrrolidine Derivatives as Muscarinic Receptor Antagonists
JP3044055B2 (ja) １，２―エタンジオール誘導体およびその塩
CA1294961C (en) Aminoalcohols, their preparation process and their applications, particularly in therapeutics
Olesen et al. 3-(3-Alkylthio-1, 2, 5-thiadiazol-4-yl)-1-azabicycles. Structure—activity relationships for antinociception mediated by central muscarinic receptors
EP1558610B1 (en) Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands
CZ26699A3 (cs) Arylcykloalkankarboxylát, jeho použití, farmaceutický přípravek a příprava
KATO et al. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxybenzamides with six-and seven-membered heteroalicycles as potential gastroprokinetic agents
EP1633752B1 (en) Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
JP2008513380A (ja) ４級アンモニウム基を有するキヌクリジン化合物とその調製方法、およびアセチルコリン遮断剤としての用途
WO2023249873A2 (en) Substituted fused bicyclic compounds and related methods of treatment
CA2353972A1 (en) Processes for the preparation of novel naphthyridine derivatives
WO2003014089A1 (en) Aminotetrahydroisoquinoline derivatives as analgesics